Advertisement

Pharmakologie

  • W. E. Müller
  • W. Juretzek

Zusammenfassung

Die pharmakologischen Wirkungen der wie oben charakterisierten Ginkgo-biloba-Spezialextrakte umfassen:
  • Radikalfängereigenschaften,

  • PAF (platelet activating factor)-Antagonismus,

  • Neuroprotektion durch Membranprotektion, Steigerung der Hypoxietoleranz, antiischämische Wirkung, Hemmung des zytotoxischen Hirnödems, Schutz vor Läsion zerebraler Strukturen, Hemmung von programmiertem Zelltod (Apoptose),

  • Beeinflussung des zentralen cholinergen Systems, Verringerung altersbedingter Defizite der Neurotransmission,

  • Verbesserung von Gedächtnisleistung und Lernvermögen,

  • hämodynamische, vaskuläre und hämorheologische Effekte.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anadere I, Chmiel H, Witte S (1985) Hemorheological findings in patients with completed stroke and the influence of a Ginkgo biloba extract. Clin Hemorheol 5: 411–420Google Scholar
  2. Artmann GM, Schikarski C (1993) Ginkgo biloba extract (EGb 761) protects red blood cells from oxidative damage. Clin Hemorheol 13: 529–539Google Scholar
  3. Artmann G, Degenhardt R, Wolff H, Grebe R, Schmid-Schönbein H (1991) Pilotstudie über membranpharmakologische Wirkungen von Ginkgo-biloba-Extrakt: Parameter-Exploration in vitro und Reduplikation der Effekte nach enteraler und parenteraler Zugabe von Rökan. In: Kemper FH, Schmid-Schönbein H (Hrsg) Rökan, Bd 1. Springer, Berlin Heidelberg New York Tokyo, S 47–62Google Scholar
  4. Barkats M, Venault P, Christen Y, Cohen-Salmon C (1995) Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains. Life Sci 56: 213–222PubMedCrossRefGoogle Scholar
  5. Barth SA, Inselmann G, Engemann R, Heidemann HT (1991) Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation in human liver microsomes in comparison to vitamin E, glutathione and N-acetylcysteine. Biochem Pharmacol 41: 1521–1526PubMedCrossRefGoogle Scholar
  6. Beck T, Abdel-Rahman MM, Bielenberg GW, Oberpichler H (1986) Comparative study on the effects of two extract fractions of Ginkgo biloba on local cerebral blood flow and on brain energy metabolism in the rat under hypoxia. In: Krieglstein J (ed) Pharmacology of cerebral ischemia. Elsevier, Amsterdam, pp 345–350Google Scholar
  7. Belougne E, Aguejouf O, Imbault P, Azougagh Oualane F, Doutremepuich F, Droy-Lefaix MT, Doutremepuich C (1996) Experimental thrombosis model induced by laser beam. Application of aspirin and an extract of ginkgo biloba: EGb 761. Thromb Res 82: 453–458PubMedCrossRefGoogle Scholar
  8. Biber A (1995) Dr. Willmar Schwabe Arzneimittel (persönliche Mitteilung)Google Scholar
  9. Blavet N (1992) Effect of Ginkgo biloba extract (EGb 76l) on learning in the aged rat. In: Christen Y, Costentin J, Lacour M (eds) Effect of Ginkgo biloba extract (EGb 761) on the central nervous system. Elsevier, Paris, pp 119–127Google Scholar
  10. Bolanos-Jimenez F, Manhaes De Castro R, Sarhan H, Prudhomme N, Drieu K, Fillion G (1995) Stress-induced 5-HT1A receptor desensitization: protective effects of Ginkgo biloba extract (EGb 761). Fundam Clin Pharmacol 9: 169–174PubMedCrossRefGoogle Scholar
  11. Borzeix MG (1985) Effects of Ginkgo biloba extract on two types of cerebral edema. In: Agnoli A, Rapin J R, Scapagnini V, Weitbrecht WV (eds) Effects of Ginkgo biloba extract on organic cerebral impairment. John Libbey, London, pp 51–56Google Scholar
  12. Borzeix MG, Labos M, Hartl C (1980) Recherches sur l’action antiagrégante de l’extrait de Ginkgo biloba. Sem Hop Paris 56: 393–398PubMedGoogle Scholar
  13. Boulieu R, Munoz JF, Macovschi O, Pacheo H (1988) Implication de la peroxydation lipidique dans l’intoxication par le triéthyltin chez le Rat. Compt Rend Sean Soc Biol (Paris) 182: 196–201Google Scholar
  14. Brailowsky S, Montiel T, Hernandez-Echeagaray E, Flores-Hernandez J, Hernandez-Pineda R (1991) Effects of a Ginkgo biloba extract on two models of cortical hemiplegia in rats. Restor Neurol Neurosci 3: 267–274PubMedGoogle Scholar
  15. Brailowsky S, Montiel T, Medina-Ceja L (1995) Acceleration of functional recovery from motor cortex ablation by two Ginkgo biloba extracts in rats. Restor Neurol Neurosci 8: 163–167PubMedGoogle Scholar
  16. Braquet P (1987) The Ginkgolides: potent platelet-activating factor antagonists isolated from Ginkgo biloba L.: chemistry, pharmacology and clinical applications. Drugs of the Future 12: 643–699Google Scholar
  17. Chatterjee SS (1985) Effects of Ginkgo biloba extract on cerebral metabolic processes. In: Agnoli A, Scapagnini V, Weitbrecht WV (eds) Effects of Ginkgo biloba extract on organic cerebral impairment. John Libbey, London, pp 5–15Google Scholar
  18. Chatterjee SS, Trunzler G (1981) Neue Ergebnisse aus der Ginkgo-Forschung. Ärztez Naturheilverf 22: 593–604Google Scholar
  19. Chatterjee SS, Gabard B (1981) Protective effect of an extract of Ginkgo biloba and other hydroxyl radical scavengers against hypoxia. Abstract, 8th International Congress of Pharmacology, Tokyo, July 19–24, p 483Google Scholar
  20. Chatterjee SS, Gabard B (1982a) Studies on the mechanism of action of an extract of Ginkgo biloba, a drug used for treatment of ischemic vascular diseases. Naunyn Schmiedebergs Arch Pharmacol [Suppl] 321: R 52, Abstr 207Google Scholar
  21. Chatterjee SS, Gabard B (1982b) Protection of Doxorubicin toxicity by an extract of Ginkgo biloba. Naunyn Schmiedebergs Arch Pharmacol [Suppl] 319: R 15, Abstr 57Google Scholar
  22. Chatterjee SS, Gabard B (1984) Effect of an extract of Ginkgo biloba on experimental neurotoxicities. Naunyn Schmiedebergs Arch Pharmacol [Suppl] 325: R 82, Abstr 327Google Scholar
  23. Chatterjee SS, Nöldner M (1989) Behavioural observations demonstrating influence of the extract of Ginkgo biloba (EGb 761) on some specific central cholinergic systems. Naunyn Schmiedebergs Arch Pharmacol [Suppl] 339: R 107, Abstr 425Google Scholar
  24. Chatterjee SS, Gabard B, Jaggy H (1986) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies. US Patent Nr 4,571, 407 (Febr 18, 1986)Google Scholar
  25. Continella G, Drago F (1985) Behavioral effects of Ginkgo biloba extract. In: Agnoli A, Rapin J R, Scapagnini V, Weitbrecht WV (eds) Effects of Ginkgo biloba extract on organic cerebral impairment. John Libbey, London, pp 35–42Google Scholar
  26. Deby C, Deby-Dupont G, Dister M, Pincemail J (1993) Efficiency of Ginkgo biloba extract (EGb 761) in neutralizing ferryl ion-induced peroxidations: therapeutic implications. In: Ferradini C, Droy-Lefaix MT, Christen Y (eds) Ginkgo biloba extract (EGb 761) as a freeradical scavenger. Elsevier, Paris, pp 13–26 (Adv Ginkgo Biloba Extract Res, vol 2)Google Scholar
  27. Denise P, Bustany P (1989) The effect of extract of Ginkgo biloba (EGb 761) on central compensation of a total unilateral peripheral vestibular deficit in the rat. In: Lacour M, Toupet M, Denise P, Christen Y (eds) Vestibular compensation: facts, theories and clinical perspectives. Elsevier, Paris, pp 201–208Google Scholar
  28. Didier A, Rouiller D, Coronas V, Jourdan F, Droy-Lefai MT (1996) Effects of Ginkgo biloba extract (EGb 761) on apoptosis and regeneration of primary olfactory neurons following target ‘lesioning’ in rats. In: Christen Y, Droy-Lefaix MT, Macias-Nunez JF (eds) Effects of Ginkgo biloba extract (EGb 761) on neuronal plasticity. Elsevier, Paris, pp 45–52 (Adv Ginkgo Biloba Extract Res, vol 5)Google Scholar
  29. Dorman DC, Coté LM, Buck WB (1992) Effects of an extract of Ginkgo biloba on bromethalin induced cerebral lipid peroxidation and edema in rats. Am J Vet Res 53: 138–142PubMedGoogle Scholar
  30. Droy-Lefaix MT, Bonhomme B, Doly M (1991) Protective effect of Ginkgo biloba extract (EGb 761) on free radical-induced changes in the electroretinogram of isolated rat retina. Drugs Exp Clin Res 17: 571–574PubMedGoogle Scholar
  31. Dumont E, Petit E, Tarrade T, Nouvelot A (1992) UV-C irradiation-induced peroxidative degradation of microsomal fatty acids and proteins. Protection by an extract of Ginkgo biloba (EGb 761). Free Rad Biol Med 13: 197–203PubMedCrossRefGoogle Scholar
  32. Dumont E, D’arbigny P, Nouvelot A (1995) Protection of polyunsaturated fatty acids against iron-dependent lipid peroxidation by a Ginkgo biloba extract (EGb 761). Meth Find Exp Clin Pharmacol 17: 83–88Google Scholar
  33. Erdincler DS, Karakov Y, Toplan S, önen S, Sikyasyan A, Beger T, Demiroglu C (1996) The effect of Ginkgo biloba glycoside on the blood viscosity and erythrocyte deformability. Clin Hemorheol 16: 271–276Google Scholar
  34. Ernst E, Matrai A (1986) Hämorheologische invitro-Effekte von Ginkgo biloba. Herz/Kreislauf 18: 358–360Google Scholar
  35. Ernst E, Marshall M (1992) Der Effekt von Ginkgo-biloba-Spezialextrakt EGb 761 auf die Leukozytenfilterabilität — eine Pilotstudie. Perfusion 5: 241–242Google Scholar
  36. Fourtillan JB, Brisson AM, Girault J, Ingrand I, Decourt JP, Drieu K, Jouenne P, Biber A (1995) Propriétés pharmacocinétiques du Bilobalide et des Ginkgolides A et B chez le sujet sain après administrations intraveineuses et orales d’extrait de Ginkgo biloba (EGb 761). Thérapie 50: 137–144PubMedGoogle Scholar
  37. Gardès-Albert M, Ferradini C, Sekaki A, Droy-Lefaix MT (1993) Oxygen-centered free radicals and their interactions with EGb 761 or CP 202. In: Ferradini C, Droy-Lefaix MT, Christen Y (eds) Ginkgo biloba extract (EGb 761) as a free-radical scavenger. Elsevier, Paris, pp 1–11 (Adv Ginkgo Biloba Extract Res, vol 2)Google Scholar
  38. Grebe R, Artmann G, Wolff H, Degenhardt R, Schmid-Schönbein H (1991) Hochauflösende mikrorheologische Methoden zum Studium pharmakodynamischer Wirkungen von Ginkgo-biloba-Extrakt an menschlichen Erythrozyten. In: Kemper FH, Schmid-Schönbein H (Hrsg) Rökan, Bd 1. Springer, Berlin Heidelberg New York Tokyo, S 31–45Google Scholar
  39. Grosdemouge C, Le Poncin-Lafitte M, Rapin JR (1986) Effets protecteurs de l’extrait de Ginkgo biloba sur la rupture précoce de la barriere hémoencéphalique chez le rat. Presse Méd 15: 1502–1505PubMedGoogle Scholar
  40. Guinot P, Caffrey E, Lambe R, Darragh A (1989) Tanakan inhibits platelet-activating-factor induced platelet aggregation in healthy male volunteers. Haemostasis 19: 219–233PubMedGoogle Scholar
  41. Heiss WD, Zeiler K (1978) Medikamentöse Beeinflussung der Hirndurchblutung. Pharmakotherapie 1: 137–144Google Scholar
  42. Hofferberth B (1991) Simultanerfassung elektrophysiologischer, psychometrischer und Theologischer Parameter bei Patienten mit hirnorganischem Psychosyndrom und erhöhtem Gefäßrisiko. Eine placebo-kontrollierte Doppelblindstudie mit Ginkgo biloba-Extrakt EGb 761. In: Stodtmeister R, Pillunat LE (Hrsg) Mikrozirkulation in Gehirn und Sinnesorganen. Enke, Stuttgart, S 64–74Google Scholar
  43. Holgado Madruga M, Decastro S, Macias-Nunez JF (1995) Effects of Ginkgo biloba extract (EGb 761) on brain aging and oxygen freeradical metabolism in the rat. In: Christen Y, Courtois Y, Droy-Lefaix MT (eds) Adv Ginkgo Biloba Extract Res, vol 4. Elsevier, Paris, pp 71–76Google Scholar
  44. Huguet F, Tarrade T (1992) α2-Adrenoceptor changes during cerebral ageing. The effect of Ginkgo biloba-extract. J Pharm Pharmacol 44: 24–27PubMedCrossRefGoogle Scholar
  45. Huguet F, Drieu K, Piriou A (1994) Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761). J Pharm Pharmacol 46: 316–318PubMedCrossRefGoogle Scholar
  46. Iliff LD, Auer LM (1983) The effect of intravenous infusion of Tebonin (Ginkgo biloba) on pial arteries in cats. J Neurosurg Sci 27: 227–231PubMedGoogle Scholar
  47. Inselmann G, Blöhmer A, Kottny W, Nellessen U, Hänel H, Heidemann HT (1995) Modification of cisplatin-induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, deferoxamine and torbafylline. Nephron 70: 425–429PubMedCrossRefGoogle Scholar
  48. Itil T, Martorano D (1995) Natural substances in psychiatry (Ginkgo biloba in dementia). Psychopharmacol Bull 31: 147–158PubMedGoogle Scholar
  49. Itil TM, Eralp E, Tsambis E, Itil KZ, Stein U (1996) Central nervous system effects of Ginkgo biloba, a plant extract. Am J Ther 3: 63–73PubMedCrossRefGoogle Scholar
  50. Itil TM, Ahmed I, Lebars P, Itil KZ (1998) The pharmacological effects of Ginkgo biloba (GB), a plant extract, on the brain of dementia patients in comparison to Tacrine. Psychopharmacol Bull 34: 391–397PubMedGoogle Scholar
  51. Janssens D, Michels C, Delalive E, Eliaers F, Drieu K, Remacle J (1995) Protection of hypoxiainduced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobalide. Biochem Pharmacol 50: 991–999PubMedCrossRefGoogle Scholar
  52. Jung F, Mrowietz C, Kiesewetter H, Wenzel E (1990) Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung 40: 589–593PubMedGoogle Scholar
  53. Karcher L, Zagermann P, Krieglstein J (1984) Effect of an extract of Ginkgo biloba on rat brain metabolism in hypoxia. Naunyn Schmiedebergs Arch Pharmacol 327: 31–35PubMedCrossRefGoogle Scholar
  54. Klein J, Chatterjee SS, Löffelholz K (1997) Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res 755: 347–350PubMedCrossRefGoogle Scholar
  55. Klein P (1988) Untersuchung über die Hemmwirkung von Ginkgo-biloba-Extrakt. Therapiewoche 38: 2379–2383Google Scholar
  56. Koch E, Chatterjee SS (1993) Experimentelle Grundlagen für die therapeutische Anwendung von Ginkgoextrakt EGb 761. Hämostaseologie 13: 11–27Google Scholar
  57. Költringer P, Eber O, Lind P, Langsteger W, Wakonig P, Klima G, Rothlauer W (1989) Mikrozirkulation und Viskoelastizität des Vollblutes unter Ginkgo-biloba-Extrakt. Eine plazebokontrollierte, randomisierte Doppelblind-Studie. Perfusion 1: 28–30Google Scholar
  58. Költringer P, Langsteger W, Klima G, Reisecker F, Eber O (1993) Hämorheologische Effekte des Ginkgo-biloba-Extrakts EGb 761. Fortschr Med 111: 170–172PubMedGoogle Scholar
  59. Költringer P, Langsteger W, Eber O (1995) Dose-dependent hemorheological effects and microcirculatory modifications following intravenous administration of Ginkgo biloba special extract EGb 761. Clin Hemorheol 15: 649–656Google Scholar
  60. Krieglstein J, Heuer H (1986) über die Brauchbarkeit eines Modells der akuten Hypoxie zur Testung zerebroprotektiver Pharmaka. Arzneimittelforschung 36: 1568–1571PubMedGoogle Scholar
  61. Krieglstein J, Oberpichler H (1989) Ginkgo biloba und Hirnleistungsstörungen. Pharmazeut Z 134: 2279–2289Google Scholar
  62. Krieglstein J, Beck T, Seibert A (1986) Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 39: 2327–2334PubMedCrossRefGoogle Scholar
  63. Krieglstein J, Ausmeier F, Eel-Abhar H, Lippert K, Welsch M, Rupalla K, Henrich-Noack P (1995) Neuroprotective effects of Ginkgo biloba constituents. Eur J Pharm Sci 3: 39–48CrossRefGoogle Scholar
  64. Kristofikova Z, Benesova O, Tejkalova H (1992) Changes of high-affinity choline uptake in the hippocampus of old rats after long-term administration of two nootropic drugs (Tacrine and Ginkgo biloba extract). Dementia 3: 304–307Google Scholar
  65. Künkel H (1993) EEG profile of three different extractions of Ginkgo biloba. Neuropsychobiology 27: 40–45PubMedCrossRefGoogle Scholar
  66. Lacour M, Ez-Zaher L, Raymond J (1991) Plasticity mechanisms in vestibular compensation in the cat are improved by an extract of Ginkgo biloba (EGb 761). Pharmacol Biochem Behav 40: 367–379PubMedCrossRefGoogle Scholar
  67. Larsen RG, Dupeyron JP, Boulu RG (1978) Modèle d’ischémie cérébrale expérimentale par microsphères chez le rat. Etude de l’effet de deux extraits de Ginkgo biloba et du naftidrofuryl. Thérapie 33: 651–660PubMedGoogle Scholar
  68. Le Poncin-Lafitte M, Rapin J, Rapin JR (1980) Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats. Arch Int Pharmacodyn 243: 236–244PubMedGoogle Scholar
  69. Maass B, Silberzahn J, Simon R (1987) Zur Wirkung von Ginkgo-biloba-Extrakt auf die Wasserstoff-Auswaschvorgänge an der Cochleabasis unter hypotensiver Ischämie. Extraeta Otorhinolaryngol 9: 169–172Google Scholar
  70. Macovschi O, Prigent AF, Nemoz G, Pacheco H (1987) Effects of an extract of Ginkgo biloba on the 3′,5′-Cyclic AMP Phosphodiesterase activity of the brain of normal and triethyltin-intoxicated rats. J Neurochem 49: 107–114PubMedCrossRefGoogle Scholar
  71. Maitra I, Marcocci L, Droy-Lefaix MT, Packer L (1995) Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol 49: 1649–1655PubMedCrossRefGoogle Scholar
  72. Marcocci L, Maguire J, Droy-Lefaix MT, Packer L (1994a) The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Comm 201: 748–755PubMedCrossRefGoogle Scholar
  73. Marcocci L, Packer L, Droy-Lefaix MT, Sekaki A, Gardes-Albert M (1994b) Antioxidant Action of Ginkgo biloba extract EGb 761. Meth Enzymol 234: 462–475PubMedCrossRefGoogle Scholar
  74. Moreau JP, Eck CR, Mccabe J, Skinner S (1986) Absorption, distribution et élimination de l’extrait marqué de feuilles de Ginkgo biloba chez le rat. Presse Méd 15: 1458–1461PubMedGoogle Scholar
  75. Ni Y, Zhao B, Hou J, Xin W (1996) Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals. Neurosci Lett 214: 115–118PubMedCrossRefGoogle Scholar
  76. Nieder M (1991) Pharmakokinetik der Ginkgo-Flavonole im Plasma. Münch Med Wochenschr 133 [Suppl 1]: S61–S62Google Scholar
  77. Oberpichler H, Beck T, Abdel-Rahman MM, Bielenberg GW, Krieglstein J (1988) Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol Res Commun 20: 349–368PubMedCrossRefGoogle Scholar
  78. Oberpichler H, Sauer D, Rossberg CH, Mennel HD, Krieglstein J (1990) PAF antagonist ginkolide B reduces postischemic neuronal damage in rat brain hippocampus. J Cereb Blood Flow Metab 10: 133–135PubMedCrossRefGoogle Scholar
  79. Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K (1996) Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 712: 349–352PubMedCrossRefGoogle Scholar
  80. Packer L, Haramaki N, Kawabata T, Marcocci L, Maitra I, Maguire JJ, Droy-Lefaix MT, Sekaki AH, Gardès-Albert M (1995) Ginkgo biloba extract (EGb 761): antioxidant action and prevention of oxidative stress-induced injury. In: Christen Y, Courtois Y, Droy-Lefaix MT (eds) Adv Ginkgo Biloba Extract Res, vol 4. Elsevier, Paris, pp 23–47Google Scholar
  81. Panetta T, Marcheselli VL, Braquet D, Spinnewyn B, Bazan NG (1987) Effects of platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemic-reperfusion induced cerebral injury. Biochem Biophys Res Commun 149: 580–587PubMedCrossRefGoogle Scholar
  82. Pardon MC, Barkats M, Venault P, Christen Y, Cohen-Salmon C (1996) Effect of long-term treatment with Ginkgo biloba extract (EGb 76l) on age-dependent structural changes in the hippocampus and spatial memory performance of inbred mice. In: Christen Y, Droy-Lefaix MT, Macias-Nunez JF (eds) Adv Ginkgo Biloba Extract Res, vol 5. Elsevier, Paris, pp 21–33Google Scholar
  83. Pignol B, Etienne A, Crastes De Paulet A, Deby C, Mencia-Huerta JM, Braquet P (1988) Role of flavonoids in the oxygen-free radical modulation of the immune response. Prog Clin Biol Res 280: 173–182PubMedGoogle Scholar
  84. Pincemail J, Deby C (1986) Propriétés antiradicalaires de l’extrait de Ginkgo biloba. Presse Méd 15: 1475–1479PubMedGoogle Scholar
  85. Pincemail J, Dupuis M, Nasr C, Hans P, Haag-Berrurier M, Anton R, Deby C (1989) Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia 45: 708–712PubMedCrossRefGoogle Scholar
  86. Prehn JM, Krieglstein J (1993) Platelet-activating factor antagonist reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 34: 179–188PubMedCrossRefGoogle Scholar
  87. Ramassamy C, Girbe F, Christen Y, Costentin J (1993) Ginkgo biloba extract EGb 761 or trolox C prevent the ascorbic acid/FE2+ induced decrease in synaptosomal membrane fluidity. Free Rad Res Commun 19: 341–350CrossRefGoogle Scholar
  88. Rapin JR, Lamproglou I, Drieu K, Defeudis FV (1994) Demonstration of the „Anti-Stress“ activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task. Gen Pharmacol 25: 1009–1016PubMedCrossRefGoogle Scholar
  89. Ravel N, Chabaud P, Mannino S, Vigouroux M, Gervais R, Droy-Lefaix MT (1996) Ginkgo biloba extract and short-term olfactory memory. In: Christen Y, Droy-Lefaix MT, Macias-Nunez JF (eds) Adv Ginkgo Biloba Extract Res, vol 5. Elsevier, Paris, pp 35–43Google Scholar
  90. Reuse-Blom S, Drieu K (1986) Effet de l’extrait de Ginkgo biloba sur le spasme artériolaire chez le lapin. Presse Méd 15: 1520–1523PubMedGoogle Scholar
  91. Rodriguez EB De Turco, Droy-Lefaix MT, Bazan NG (1993) Decreased electroconvulsive shock-induced diacylglycerols and free fatty acid accumulation in the rat brain by Ginkgo biloba extract (EGb 761): selective effect in hippocampus as compared with cerebral cortex. J Neurochem 61: 1438–1444CrossRefGoogle Scholar
  92. Rong Y, Geng Z, Lau BHS (1996) Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells. Free Rad Biol Med 20: 121–127PubMedCrossRefGoogle Scholar
  93. Rudofsky G (1987) Wirkung von Ginkgo-biloba-Extrakt bei arterieller Verschlußkrankheit. Fortschr Med 105: 397–400PubMedGoogle Scholar
  94. Sancesario G, Kreutzberg GW (1986) Stimulation of astrocytes affects cytotoxic brain edema. Acta Neuropathol (Berl) 72: 3–14CrossRefGoogle Scholar
  95. Schaffler K, Reeh PW (1985) Doppelblindstudie zur hypoxieprotektiven Wirkung eines standardisierten Ginkgo-biloba-Präparates nach Mehrfachverabreichung an gesunden Probanden. Arzneimittelforschung 35: 1283–1286PubMedGoogle Scholar
  96. Sharma HS, Westman J, Nyberg F, Cervos-Navarro J, Dey PK (1994) Neuroprotective effects of an extract of Ginkgo biloba (EGb 761) in heat stress induced brain damage in the rat. In: Zeisberg E, Schönbaum E, Lomax P (eds) Thermal balance in health and disease. Birkhäuser, Basel, pp 461–467 (Adv Pharmacol Sci)CrossRefGoogle Scholar
  97. Spiess E, Juretzek W (1993) Ginkgo. In: Hansel R, Keller K, Rimpler H, Schneider G (Hrsg) Hagers Handbuch der Pharmazeutischen Praxis, Bd 5. Drogen E-O. Springer, Berlin Heidelberg New York, S 269–292Google Scholar
  98. Spinnewyn B, Blavet N, Clostre F (1986) Effets de l’extrait de Ginkgo biloba sur un modèle d’ischémie cérébrale chez la gerbille. Presse Méd 15: 1511–1515PubMedGoogle Scholar
  99. Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P (1987) Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils. Prostaglandins 34: 337–349PubMedCrossRefGoogle Scholar
  100. Srám RJ, Binkova B, Stejskalova J, Topinka J (1993) Effect of EGb 761 on lipid peroxidation, DNA repair and antioxienzyme activity. In: Ferradini C, Droy-Lefaix MT, Christen Y (eds) Adv Ginkgo Biloba Extract Res, vol 2. Elsevier, Paris, pp 27–38Google Scholar
  101. Stoll S, Scheuer K, Pohl O, Mueller WE (1996) Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiat 29: 144–149CrossRefGoogle Scholar
  102. Stücker O, Pons C, Duverger JP, Drieu K (1996) Effects of Ginkgo biloba extract (EGb 761) on arteriolar spasm in a rat cremaster muscle preparation. Int J Microcirc 16: 98–104CrossRefGoogle Scholar
  103. Stücker O, Pons C, Duverger JP, Drieu K, D’arbigny P (1997) Effect of Ginkgo biloba Extract (EGb 761) on the vasospastic response of mouse cutaneous arterioles to platelet activation. Int J Microcirc 17: 61–66CrossRefGoogle Scholar
  104. Taylor JE (1986) Liaison des neuromédiateurs à leurs récepteurs dans le cerveau de rats. Presse Méd 15: 1491–1493PubMedGoogle Scholar
  105. Tea S, Celsis P, Clanet M, Marc-Vergnes JP, Boeters U (1987) Quantifizierte Parameter zum Nachweis von zerebraler Durchblutungs-und Stoffwechselsteigerung unter Ginkgo-biloba-Therapie. Therapiewoche 37: 2655–2657Google Scholar
  106. Winter E (1991) Effects of an extract of ginkgo biloba on learning and memory in mice. Pharmacol Biochem Behav 38: 109–114PubMedCrossRefGoogle Scholar
  107. Witte S (1993) Klinische Ergebnisse über hämorheologische Wirkungen von Ginkgo-biloba-Extrakt. Hämostaseologie 13: 35–42Google Scholar
  108. Witte S, Anadere I, Walitza E (1992) Verbesserung der Hämorheologie durch Ginkgobiloba-Extrakt. Fortschr Med 110: 247–250PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 1999

Authors and Affiliations

  • W. E. Müller
  • W. Juretzek

There are no affiliations available

Personalised recommendations